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Functional and structural alterations of the glomerular permeability
barrier in experimental galactosemia. Experimental galactosemia, in-
duced by feeding rats a galactose enriched diet, reproduces many of the
neural and ocular complications of diabetes and induces protein glyca-
tion and polyol accumulation. To explore the role of these biochemical
abnormalities in the pathogenesis of glomerular injury, adult male
Sprague-Dawley rats were placed on either a 50% galactose or 50%
glucose diet, After two months, galactose fed rats exhibited elevated
excretory rates of protein, albumin, and IgG. Blebbing and ballooning
of the glomerular epithelial cells were apparent in rats on the galactose
supplemented diet. Morphometric evaluation of the glomeruli revealed
an increase in the fractional and absolute volume of the glomerular
epithelial cells, but glomerular and mesangial volume, basement mem-
brane thickness, and epithelial foot process width were similar on the
two diets. Glycation of the glomerular basement membrane was in-
creased in the galactose fed rats. Glomerular micropuncture revealed
similar glomerular pressures and flow rates on the two diets. Aldose
reductase inhibition had no effect on galactose induced proteinuria.
These results suggest that biochemical abnormalities such as protein
glycation may be important in the pathogenesis of altered glomerular
permselectivity in diabetic nephropathy.
Hyperglycemia contributes to the development of diabetic
complications. Patients with the best levels of glycemic control
are most likely to avoid nephropathy and those with the poorest
glycemic control appear to be at the greatest risk [1]. Two
biochemical pathways are major candidates for mediating the
injurious effects of glucose in diabetes: polyol accumulation [2]
and protein glycation [31. However, the contribution of these
processes to the genesis of diabetic complications has been
difficult to discern because of the coexistence of a variety of
additional hormonal and hemodynamic abnormalities in both
diabetic humans and experimental models.
Experimental galactosemia results in the formation of polyol
accumulation and protein glycation, similar to that of the
hyperglycemia of diabetes. The action of the enzyme aldose
reductase on galactose results in the formation of galactitol. The
accumulation of sugar alcohol within the cell, whether sorbitol
in hyperglycemia or galactitol in galactosemia, may be associ-
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ated with cellular dysfunction [2]. Protein glycation, produced
by the non-enzymatic reaction of glucose or galactose with an
amine group on a protein, may perturb functional or structural
properties of protein such as enzyme or receptor activity or
collagen stability [3, 41. That such disturbances of protein and
cellular structure and function may culminate in tissue injury is
indicated by the well described diabetic-like lesions in the lens
[5], retina [6], and peripheral nerve [71 in experimental galac-
tosemia. This study examines the functional and structural
abnormalities induced in the glomerulus after galactose feeding
in rats.
Methods
Adult male Sprague-Dawley rats weighing 250 to 275 g were
matched for age and weight and placed on either a 50% glucose
or a 50% galactose diet (ICN, Cleveland, Ohio, USA). Rats
were allowed free access to food and water. Other elements of
the diet including lipids, minerals and protein were identical.
The protein content was 25% as casein.
Rats were placed on the diets for two months. Twenty-four
hour urine samples were obtained at one and two months for
determination of total protein, IgG, and albumin excretion.
Renal tissue was perfused at each rat's mean arterial pressure
with 1.25% glutaraldehyde in 0.1 M sodium cacodylate buffer
(pH 7.4). Kidneys that blanched immediately after the start of
the perfusion were used for morphometric studies. Four to five
coronal slices of tissue were processed for light microscopic
evaluation. Three micron paraffin sections were stained with
hematoxylin and eosin. One mm3 pieces of renal cortex were
block stained with osmium, dehydrated in acetone, imbedded in
epon araldite, and "silver" sections were evaluated on a
Hitachi 600 electron microscope.
A separate set of seven galactose and seven glucose fed rats
were studied weekly for one to four weeks after initiation of
dietary intervention to establish the time course of proteinuria
and plasma protein glycation. Whole blood was collected in
heparinized capillary tubes, and the plasma was separated
following centrifugation.
To determine the effects of aldose reductase inhibition on
proteinuria, rats were placed on either a galactose or a galactose
plus statil (25 mg/kg rat weight administered in the food; IC!,
Wilmington, Delaware, USA) and urine was collected after two
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months for determination of urinary protein excretion. Food
consumption and rat weight was monitored weekly. Cataract
formation, defined as homogeneous opacity of the lens, was
assessed visually at two months.
Morphometry
The mean glomerular tuft volume (VG) was determined from
light microscopy using point counting techniques and the equa-
tion
V0 = l.25(A)
where AG is the mean glomerular cross-sectional area and 1.25
is a constant based on the shape and sectioning characteristics
of the glomerulus [8]. At least 100 glomeruli from each animal
were examined. The evaluation was started at the upper left
hand corner of the slide, the slide scanned in a set pattern, and
the first 100 glomeruli to be encountered were included in this
assessment.
Epithelial cell and mesangial volumes were determined from
electron micrographs printed at a final magnification of approx-
imately 3500 power and assembled as a montage of the entire
glomerulus. Three glomeruli were evaluated in each rat. The
volume fraction of mesangium (V) was calculated as:
(V ) = P(mes)
glomerulus)
where (g1omerulus) represents the number of points falling on
the glomerulus and "(mes) represents the number of points
falling on mesangial cells and matrix [8]. The absolute volume
of mesangium (V(mes)) was calculated as
V(mes) = Vv)
The volume fraction of epithelial cells (VV(.) was calculated
P(epi)Vv) =
P(gIomeruIus)
as
where (epi) is the number of points falling on epithelial cells.
Absolute epithelial cell volume ((epi)) was calculated as
V(epi) = V(epi)Glomerular basement membrane thickness was determined
from approximately 25 electron micrographs taken in an unbi-
ased manner from two glomeruli in each rat and printed to a
final magnification of approximately 40,000 power. The glomer-
ular basement membrane thickness (TGBM) was determined as
TGBM = 8/3 ir- l06/M. 1h where M magnification and 1h is
the harmonic mean apparent GBM thickness classified using a
log reciprocal scale as described by Hirose et al [8]. The actual
magnification of all electron micrographs was determined by
photographing a reference grid prior to photographing each
glomerular section and printing it in an identical manner to the
electron photomicrographs.
Epithelial foot process width was determined in an identical
manner to TGBM, except that an enlarged scale was used [9].
Micropuncture
Renal micropuncture and clearance studies were carried out
approximately two months after initiation of the dietary inter-
vention. Rats were anesthetized with mactin (100 mg/kg i.p.). A
femoral artery catheter of PE-50 tubing was placed to monitor
arterial pressure and to obtain blood samples. A tracheostomy
was placed using PE-240 tubing, two jugular venous lines were
placed, and the left ureter was catheterized. All rats received a
plasma infusion of 1% body weight over 20 minutes to replace
surgical losses followed by 0.55 mI/hr in the glucose-fed group
and 1.1 mL/hr in the galacto se-fed group for the duration of the
study to maintain hematocrit and serum protein levels near the
pre-surgery levels.3H-inulin in saline was infused at a rate of 1.1
ml/hr at a concentration sufficient to produce approximately 300
counts/mm in a four minute collection of tubular fluid. A 23
gauge needle connected to PE-50 tubing and a tuberculin
syringe was placed in the renal vein for collection of renal
venous samples. Glomerular micropressures were determined
by the stop-flow technique using a servo null device (Instru-
mentation for Physiology and Medicine, San Diego, California,
USA). Whole kidney clearance data was obtained from two
20-minute periods with renal vein and femoral artery samples
collected at the midpoint. SNGFR was determined from three
to four collections from randomly selected proximal tubules.
Filtration fraction was determined by the renal extraction of
inulin. Arteriolar resistances and Kf, the glomerular ultrafiltra-
tion coefficient, were calculated as previously described [10].
Assays
Total protein was determined by the Coomassie method, and
IgG and albumin were quantitated by rate nephelometry with
goat anti-rat antibodies (Cappel).
To quantitate glomerular basement membrane (GBM) glyca-
tion, glomeruli were isolated by differential sieving, cellular
elements lysed and solubilized with 0.5% N-lauryl sarcosine
and 0.01% DNase and the resulting GBM subjected to NaB3H4
reduction to tritiate sites of glycation. GBM was hydrolyzed in
hydrochloric acid, neutralized with NaOH and subjected to
phenylboronic acid chromatography to bind glycated GBM
fragments, which were eluted with glucose (25 mM). Glycation
was expressed as 3H eluted from the column/mg GBM protein
[11].
To quantitate glycation of plasmaprotein, plasma was diluted
in buffered saline and subjected to phenyl boronic acid chro-
matography using a commercially available kit (Isolab). Protein
was quantitated using the Coomassie assay. Results were
expressed as the percent of total plasma protein which was
glycated.
Statistical analysis was performed by the two-tailed t-test and
a P < 0.05 was considered significant. Results are expressed as
mean 1 standard error (Sn).
Results
Galactose feeding resulted in cataract formation within 30
days in all of the rats studied. On the contrary, glucose feeding
was never associated with cataract formation. These findings
confirm the systemic effects of the diet-induced galactosemia.
The galactose-fed rats appeared healthy and were as active as
the glucose-fed control rats. They gained weight at a constant,
albeit slower, rate (Table 1), despite eating approximately twice
as much food per day (17 2 vs. 38 2 glday; glucose vs.
galactose; P < 0.05). Urinary excretory rates for total protein
were significantly different in the two groups of rats. At one
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Table 1. Body weight
Diet
Initial I month 2 months
g
Glucose
N = 10
Galactose
N 10
270
270
3
3
340 9
275 ioa
395
290
14
2o
ap <005
month the protein excretory rates were elevated in the galac-
tose fed rats (8 3 vs. 43 mg!24 hrs; glucose vs. galactose; P <
0.05). Similarly, the difference in proteinuria persisted after two
months (6 1 vs. 41 7 mg124 hr glucose vs. galactose, P <
0.05). To characterize the nature of the protein excretion, IgG
and albumin excretory rates were quantitated at two months
and were increased in the galactose-fed animals (Fig. 1). Kidney
weights at the time of perfusion for electron microscopy were
similar in both groups (wet kidney weight: 1.65 0.05 vs. 1.68
0.11 grams glucose vs. galactose; dry kidney weight: 0.37
0.01 vs. 39 0.03 g glucose vs. galactose).
Qualitative assessment of renal tissue by light microscopy
revealed no difference in either the glomerular, tubular, or
interstitial architecture between the two groups. Qualitative
electron microscopy revealed prominent abnormalities of the
glomerular epithelial cells in the galactose-fed animals (Figs.
2,3,4). Galactose-fed rats had enlarged, swollen glomerular
epithelial cells (Figs. 2,3) which contained amorphous cytoplas-
mic inclusions (Fig. 3). Galactose-fed rats also exhibited bleb-
bing of the cytoplasmic processes extending from the primary
cell body (Figs. 3,4) resulting in ballooning of the cell process
into Bowman's space and large spaces between the cell process
and the podocytes resting on the basement membrane. Because
these abnormalities were so striking quantitative glomerular
morphometry was performed in renal tissue from the same rats
(Table 2). Glomerular volume, a measure of glomerular hyper-
trophy, was not different on either diet. Likewise, mesangial
volume was also similar in the two groups. Epithelial cell
volumes, whether expressed as a fraction of the glomerular
volume or as an absolute volume, were significantly greater in
the galactose-fed animals, confirming the epithelial cell swelling
observed qualitatively on the electron micrographs. The width
of glomerular epithelial cell foot processes was not altered by
galactose feeding. Glomerular basement membrane thickness
was similar in the two groups (Table 2).
Glomerular micropuncture and clearance studies performed
in a separate set of rats two months after the initiation of dietary
intervention revealed no difference in mean arterial pressure,
whole kidney or single nephron glomerular filtration rate,
plasma flow rates, or filtration fraction (Table 3). The glomer-
ular capillary pressure was identical in the two groups (Table 3).
To determine the role for the accumulation of glomerular
polyols in the proteinuria observed with galactose feeding
another group of rats were fed either galactose or galactose plus
statil, an aldose reductase inhibitor, at a dose (25 mg/kg body
wt) known to decrease renal polyol accumulation. Albumin
excretion was not altered after two months of aldose reductase
inhibition (ART) (10.9 2.1 vs. 10.6 5.2 mg/24 hr galactose
vs. galactose + statil) in the two groups. Cataracts were present
uniformly in all of the galactose-fed animals but were present in
only two of the eight galactose statil-treated animals demon-
strating that the dose of statil used was adequate to prevent
polyol accumulation in the lens.
To confirm the presence of protein glycation in the galactose-
fed rats, GBM was isolated from rats fed either the glucose or
galactose diet for two months. The glomerular basement mem-
brane from the galactose animals exhibited a significantly
increased amount of protein glycation (30119 5718 vs. 46674
1040 cpm3 H/mg protein; glucose vs. galactose; P < 0.05).
The time course for the development of protein glycation and
proteinuria was assessed weekly for four weeks after initiation
of dietary intervention. Augmented proteinuria was apparent
after one week of galactose feeding (Fig. 5) and remained
elevated for the next three weeks. Plasma proteins were signif-
icantly glycated in the galactose-fed rats by the end of the first
week (Fig. 6), a time course similar to the development of
proteinuria.
Discussion
Diabetes mellitus is attended by a variety of biochemical,
hormonal, and hemodynamic alterations. However, determina-
tion of the relative contributions of biochemical and hemody-
namic alterations to the development of nephropathy has been
difficult because of their coexistence in diabetic humans and
most experimental models. Galactose feeding is a model which
replicates some of the biochemical abnormalities of diabetes
[2—41 but lacks glomerular hypertension [12] and glomerular
hypertrophy [13] and does not appear to have a consistent effect
on the glomerular filtration rate [12, 14 and the present study].
Elevated levels of plasma galactose, whether in humans or
experimental animals, lead to protein glycation, polyol accumu-
lation, and the development of glycation related protein
crosslinks and experimental galactosemia has been taken as a
model for the lens and neural complications of diabetes. How-
ever, galactose induced glomerular abnormalities are not well
defined. Proteinuria, with an electrophoretic pattern identical to
plasma, has been noted in infants with galactosemia and is
reversed following introduction of a galactose free diet [15]. In
rat models of galactosemia, proteinuria is evident but is present
at relatively low levels [16 and the present study]. Alterations in
proximal tubular function are reported in some, but not all,
types of human galactosemia and could contribute to tubular or
low molecular weight proteinuria [17]. However, in the present
study, abnormalities in both the structure and function of the
glomerular permselectivity barrier were apparent in rats sub-
jected to galactose feeding. The increase in protein excretory
rates seen in the galactose-fed animals is associated with an
increase in both albumin and IgG excretion, indications of
defects in the glomerular permselectivity barrier. While alter-
ations in the proximal reabsorption of small molecular weight
proteins can result in small amounts of proteinuria, the large
size of albumin and IgG and their near negligible permeability in
a normal glomerulus indicate that their increased excretion
depends on increased glomerular permeability [18]. The abnor-
mal histology of the epithelial cells also suggests an abnormality
of the glomerular permeability barrier. The glomerular epithe-
hal cell forms a critical portion of the glomerular barrier to
protein permeability, and abnormalities of glomerular epithelial
cells accompany proteinuria of diverse etiologies [18]. In human
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diabetes, glomerular swelling is apparent [19] and in experimen-
tal diabetes in the rat epithelial alterations similar to those in the
present study have been reported [20]. Glomerular epithelial
morphology has not been reported in the galactosemic dog, but
overall glomerular morphometry is normal [13j and proteinuria
is present in only 40% of the dogs [16]. The reasons for these
discrepancies between dogs and rats and humans in the devel-
opment of galactose induced proteinuria cannot be defined from
the available literature. In experimental nephrosis, such as
produced by puromycin and adriamycin, abnormalities in the
epithelial cells such as swelling, podocyte effacement and
retraction, are prominent histologic findings and have been
P < 0.05
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Fig. 1A. Albumin excretory rates. After two months of dietary intervention, galactose fed rats had elevated albumin excretory rates. B. IgG
excretory rates. After two months of dietary intervention, galactose fed rats had elevated IgG excretory rates.
Fig. 2A. Normal epithelial cell morphology in a glucose fed rat. B. Glomerular epithelial cell swelling in a galactose fed rat. (3500x)
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Fig. 3A. Normal epirhelial cells from a glucose fed rat. B. Swollen glomerular epithelial cells with long cytoplasmic extensions (arrow), bleb
formation and intracytoplasmic inclusions (*). (3500x)
implicated in the pathogenesis of the proteinuria [21, 221. In
addition to diabetes, morphologically similar changes in the
epithelial cell to those observed in the present study, such as
blebbing of the epithelial cell processes, occur in the remnant
model of renal disease, a proteinuric renal disease [23], and
following treatment of glomeruli with cytochalasin D, an inhib-
itor of microtubule formation [24]. It is conceivable that galac-
tose could mediate alterations in microtubules or other struc-
tural proteins by glycation as occurs in the assembly of other
proteins such as GEM components in the glomerutus, Podocyte
attachment to underlying basement membrane may also be
altered by either glycation, or the accumulation of collagen
crosslinks and could contribute to altered epithelial cell mor-
phology.
Mesangial volume was not significantly increased with galac-
tose feeding as has been shown by Engerman and Kern in the
galactosemic dog [131. Increased mesangial volume accompa-
nies long term diabetes in both experimental and clinical
situations where such expansion ultimately appears to impinge
on the filtration surface and may thereby mediate the fall in
glomerular filtration rate [25]. Its absence in galactosemia
despite proteinuria argues for an independent pathogenesis of
two of those features of diabetic glomerulopathy. Perhaps the
epithelial cell abnormalities, and to some extent the proteinuria,
are more glycation dependent while mesangial changes result
more from hemodynamic or other influences. In human diabe-
tes, as well, the development of microalbuminuria may precede
the development of mesangial expansion [26], suggesting that
abnormalities of the glomerular permeability barrier occur
independently of mesangial expansion.
Glomerular basement membrane thickness is a regular ac-
companiment of clinical diabetic nephropathy but antedates
measurable proteinuria [27]. The lack of such thickening with
galactose feeding in the rat may have been due either to the
relatively short duration of the study or the absence of impor-
tant pathogenetic factors present in diabetes but absent in
galactosemia, notably glomerular capillary hypertension. Nev-
ertheless, the present results suggest that quantifiable alter-
ations in the glomerular basement membrane are not a neces-
sary factor for the development of proteinuria, at least in this
model.
Galactose feeding had no effect on either glomerular flow
rates or capillary pressures in the present study. Although
elevated glomerular micropressures have been strongly impli-
cated in experimental diabetic glomerulopathy [28, 29], the
absence of glomerular hypertension in this and other studies of
galactosemia [121 suggests that non-hemodynarnic factors may
also participate in glomerular injury in diabetes. Glomerular
hyperperfusion, regularly present in diabetes [28, 29] and re-
ported in galactosemia by some investigators [121 was absent in
the present study. Although the reason for this discrepancy is
not apparent, it does suggest that glomerular hyperperfusion is
not essential for the genesis of glomerular damage in experi-
mental galactosemia. It should be noted that the role of en-
hanced renal flow rates in mediating glomerular injury has been
questioned in diabetes, based on manipulations such as angio-
fry
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Fig. 4A. Normal epithelial cell from a glucose fed rat. B. Long, ribbon like cytoplasmic extensions (arrow) and bleb formation in glomerular
epithelial cell from a galactose fed rat. (3500x)
Table 2. Glomerular morphometry
Basement
Kidney
weight
g
Glomerular
volume
jm3 X 106
Epithelial cell volume Mesangial volume
membrane
thickness
Foot process
width
% p.m3 x 106 /.m3 x 106 nm
Glucose
N = 8 1.72 0.05 1.60 0.08 13 1 0.22 0.03 6 1 0.10 0.01 154 7 291 18
Galactose
N = 8 1.72 0.12 1.53 0.04 19 ia 0.30 o.ola 8 1 0.12 0.01 157 11 309 8
a p < 0,05 vs. glucose
tensin converting enzyme inhibition which normalize glomeru-
lar hypertension and ameliorate glomerular injury but allow
persistence of the elevated flow rates [291.
While a great deal of controversy exists surrounding the role
of aldose reductase in the genesis of hexose induced renal
injury, the lack of an effect of ARI on proteinuria in galac-
tosemia is consistent with the hypothesis that the polyol path-
way does not mediate glomerular injury in either galactosemia
or diabetes [13]. The renal galactitol levels were not quantitated
in the present study. However, the dose of statil used in this
study has been shown to prevent the accumulation of renal
sorbitol and the appearance of cataracts in diabetic rats, and the
absence of cataracts in the statil-treated galactose group offers
evidence for its systemic efficacy in the present study. Two long
term studies in the streptozotocin diabetic rat have failed to
demonstrate a beneficial effect on proteinuria [30, 31] or histol-
ogy [301, while the results in shorter studies in galactosemia are
variable [12, present studyj.
Protein glycation seems a more likely candidate for galactose
induced renal iujury. The reaction of galactose with the amino
group on a protein is analogous to that produced by the
non-enzymatic glycation of proteins by glucose in diabetes and
would be expected to alter the structure and function of
structural as well as circulating proteins. In the present study,
glycation of plasma protein and the appearance of proteinuria
occurred over a similar time period. Glycation of circulating
proteins was rapid and was at steady state levels by the end of
the first week of dietary intervention. The present study was not
designed to determine the precise mechanism of proteinuria
that might be induced by glycation, but several possibilities
exist. Glycation of glomerular basement membrane by galac-
tose was documented in this study and is present in the diabetic
glomerulus as well [32]. Glycation of a variety of basement
membrane proteins such as laminin, collagin, and fibronectin
has been documented [33—35]. The glycation of laminin results
in a decrease in its adhesive properties [34], and such a defect
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Table 3. Glomerular hemodynamics eight weeks after dietary intervention
MAP
mm
GFR
in!!
SNGFR QA PT GC 'E A RA RE K
ni/sec! Hct
Diet Hg mm nI/mm FF mm Hg x 1010 dyne sec cm5 mm Hg %
Galactose 122 101 42 148 0.29 12 56 45 14 21 1.72 1.28 0.0583 53
N = 5 ±5 ±0.11 ±2 ±13 ±0.02 ±1 ±1 ±2 ±1 ±1 ±0.15 ±0.14 ±0.0162 ±1
Glucose 117 1.05 47 153 0.31 15 56 42 17 20 1.49 1.14 0.0590 55N 5 ±4 ±0.10 ±5 ±19 ±0.03 ±1 ±1 ±1 ±1 ±1 ±0.20 ±0.14 ±0.0160 ±1
Adult rats were fed either 50% glucose or 50% galactose in the diet and subjected to micropuncture 8 weeks later.
Abbreviations are: MAP, mean arterial pressure; GFR, glomerular filtration rate; SNGFR, single nephron glomerular filtration rate; QA. single
nephron plasma flow; FF, filtration fraction; T, tubular pressure; P, glomerular capillary pressure; P, transcapillary hydraulic pressure
gradient; P1, efferent arteriolar pressure; TA, afferent oncotic pressure; RA, afferent arteriolar resistance; Ru, efferent arteriolar resistance; K,
ultrafiltration coefficient; Hct, hematocrit.
1 2 3 4
Week
Fig. 5. Time course for the development of proteinuria. One week after
dietary intervention, proteinuria was greater in the galactose fed rats
(solid line, N = 7) than the glucose fed rats (hatched line, N = 7) (P <
0,05).
may mediate an abnormal interaction between basement mem-
brane and the epithelial cell, and could eventuate in structural
abnormalities of the epithelial cell with alterations of the
glomerular permeability barrier. In addition, augmented gb-
merular permeability of circulating glycated proteins may ac-
count for some of the proteinuria and/or glomerular injury seen
in the galactose fed group. Glycated albumin, which occurs in
galactosemia, exhibits an increased urinary excretion rate rel-
ative to non-glycated albumin [361 and an increase in permeance
across the glomerular basement membrane in an in vitro filtra-
tion model [37]. The long term consequences of glycation, such
as the accumulation of cross linked "advanced glycation end-
products" are also increased in galactosemia and may contrib-
ute to the pathogenesis of renal abnormalities in galactosemia
[381.
The biochemical abnormalities of experimental galactosemia
seem to impart only a portion of the injurious effects of diabetes
on the kidney. The proteinuria was not progressive over the
study period and was less than that seen with progressive
nephropathy in diabetic rats [30]. The rapidity of development
2
Week
Fig. 6. Glycation of plasma proteins. One week after dietary interven-
tion plasma protein glycation was greater in the galactose fed rats (solid
line, N 7) than the glucose fed rats (hatched line, N = 7) (*P < 0,05).
of proteinuria in galactosemic rats as compared to diabetic rats
may be due to the increased reactivity of galactose relative to
glucose in inducing protein glycation [39]. We speculate that the
lack of a progressive rise in proteinuria results from the absence
of hemodynamic alterations and glomerular hypertrophy which
might augment glomerular injury, as in other models of renal
disease [10, 22, 40].
Although the galactose fed rats consumed twice the quantity
of food as the glucose fed rats, 50% of that diet is galactose
which is nearly unmetabolizable. Thus, caloric intake was
similar in the two groups. Protein intake, as the percent of
calories, was higher in the galactose fed rats, but they exhibit
none of the renal hemodynamic alterations which accompany
increased protein intake such as glomerular hyperperfusion,
glomerular hypertension, renal growth, or glomerular hypertro-
phy.
In summary, experimental galactosemia in the rat resulted in
an increase in albumin and IgG excretion and structural abnor-
malities of the glomerular epithelial cell. These abnormalities
occurred in the absence of hemodynamic alterations, and the
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proteinuria was not prevented with aldose reductase inhibition.
These results suggest that biochemical abnormalities such as
protein glycation may be important but not sufficient for the
genesis of altered glomerular pathology and pathophysiology in
diabetic nephropathy.
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